Avidity Biosciences
100 hedge funds and large institutions have $739M invested in Avidity Biosciences in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 43 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less capital invested
Capital invested by funds: $790M → $739M (-$51.3M)
Holders
100
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$17.7M | |
| 2 | +$14.6M | |
| 3 | +$14.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.2M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.04M |
Top Sellers
| 1 | -$17.1M | |
| 2 | -$4.92M | |
| 3 | -$4.04M | |
| 4 |
TG
TCW Group
Los Angeles,
California
|
-$3.69M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$3.58M |